PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Journal of Radiation Research0 citationsOpen Access

Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study

View Full Paper
KAKota AbeKIK. ItoMWM. Watanabe

Key Points

  • Evaluate the effectiveness of online adaptive treatment planning for SBRT boost in cervical cancer patients unsuitable for brachytherapy.
  • Conducted a retrospective analysis of 15 treatment plans from five patients.
  • Utilized daily magnetic resonance imaging to compare ADT and conventional position-alignment dose distributions.
  • Defined planning target volume as the high-risk clinical target volume plus a 3 mm margin.
  • ADT plans improved planning target volume D90%, enhancing target coverage.
  • PA plans exceeded dose constraints significantly for organ-at-risk structures across treatment fractions.
  • Average excess doses were 6.89 ± 4.39 Gy to PRV-sigmoid and 5.76 ± 3.33 Gy to PRV-rectum.

Abstract

Abstract This study aimed to evaluate the effectiveness of online adaptive treatment (ADT) planning for stereotactic body radiotherapy (SBRT) boost on a 1.5-T MR-Linac in cervical cancer patients ineligible for brachytherapy, compared with the conventional position-alignment (PA) assumed dose distributions. This retrospective analysis included 15 treatment plans from five patients, each receiving 21.0 Gy in three fractions. Daily magnetic resonance imaging (MRIs) were used to compare target and organ-at-risk (OAR) doses between ADT and PA dose distributions. The planning target volume (PTV) was defined as the high-risk clinical target volume (HR-CTV) plus a 3 mm margin. OARs included the bladder, bowel bag, and planning organ-at-risk volume (PRV) for rectum and sigmoid. Reference plans prioritized OAR constraints while maximizing target coverage; the intended PTV D90% range was 18.9–21.6 Gy. PA doses were reconstructed by dose warping based on alignment of the anterior rectal wall between daily and pretreatment MRIs, whereas ADT plans were reoptimized on the daily MRIs. HR-CTV decreased by 1.6%–41.5% between the planning MRI and the first treatment fraction. ADT plans improved PTV D90%, achieved better target coverage and met all OAR constraints, whereas PA plans showed dose constraint exceedance across the three fractions, with mean excess doses of 6.89 ± 4.39 Gy to PRV-sigmoid and 5.76 ± 3.33 Gy to PRV-rectum. In conclusion, 1.5-T MR-Linac based SBRT boost with daily online adaptation enhanced tumor coverage and reduced OAR doses, supporting MR-guided online adaptive radiotherapy as a promising option for patients ineligible for brachytherapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Abe et al. (2026) studied this question.

synapsesocial.com/papers/69cf5cd15a333a821460a680https://doi.org/10.1093/jrr/rrag013
Ask AI
Helpful
Bookmark
Share
View Full Paper